Association Between Management of Continuous Subcutaneous Basal Insulin Administration and HbA1C. (September 2022)

• Record Type: Journal Article
• Authors: Rubin-Falcone, Harry; Fox, Ian; Hirschfeld, Emily; Ang, Lynn; Pop-Busui, Rodica; Lee, Joyce M.; Wiens, Jenna
• Is Part Of: Journal of diabetes science and technology. Volume 16:Number 5(2022)
• Page Start: 1120
• Page End: 1127
• Publication Date: 2022-09
• Subjects: basal insulin -- insulin pump therapy -- patient treatment management -- type 1 diabetes; Diabetes -- Periodicals; Medical technology -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1177/19322968211004171
• Languages: English
• ISSNs: 1932-2968

Abstract

Background: While we expect that patients who adjust their insulin delivery algorithms between clinic visits to have better glucose control compared to those who do not, this effect has not been quantified. Method: This is a single-center retrospective cohort study including pediatric and adult patients with type 1 diabetes evaluating insulin pump self-management behaviors. Basal insulin dose information was obtained from the Glooko-Diasend database, and used to quantify the frequency and magnitude of basal insulin daily dose adjustments within the 90-day window preceding HbA1c measurement. We use a linear mixed-effects model to analyze associations between frequency/magnitude of daily basal insulin changes and HbA1c. Results: We present data on 114 adult (44 ± 17 years, 60% female) and 212 pediatric (12 ± 4 years, 50% female) patients. Individuals changed their basal insulin dose on 72%-94% (interquartile range [IQR]) of observed days relative to the previous day. These changes varied 0.6%-2.4% IQR from the previous day's value. In pediatric patients, lower HbA1c was associated with more frequent daily profile adjustments, while controlling for rate of hypoglycemia (z = -3.2, P = .001). In adults, there was no relationship between HbA1c and magnitude or frequency of basal profile adjustments. Conclusions: Pediatric patients who frequently modify their basal insulin exhibit somewhat better clinical outcomes, although the magnitude by which their basal amount is changed does not contribute to this effect.